Andrew L. Pecora, Director at TETRALOGIC PHARMACEUTICALS CORP (TLOG), bought 50,000 shares at $2.41 ($120K) on 2015-07-09, disclosed to the SEC on 2015-07-13.
Open-market purchase of $120k TLOG by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.40 | 40,000 | $96K | 79.9% |
| 2 | $2.41 | 10,000 | $24K | 20.1% |
| Total | $2.40 avg | 50,000 | $120K | 100% |
| Filing → |
| TLOG | BUY | 2014-11-19 | $91K | — | Filing → |
| TLOG | BUY | 2013-12-19 | $186K | — | Filing → |
| CGIX | SELL | 2013-11-20 | $713K | — | Filing → |